Rajwana Jahan

Title: Rajwana Jahan: Innovator in GABA(a) Receptor Modulation

Introduction

Rajwana Jahan is a prominent inventor based in Milwaukee, WI (US). She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target GABA(a) receptors. With a total of 2 patents, her work is paving the way for advancements in asthma treatment.

Latest Patents

Rajwana Jahan's latest patents include innovative compounds known as substituted benzo[f]imidazo[1,5-a][1,4]diazepines. These compounds are designed to act as GABA(a) receptor modulators. The first patent describes these compounds targeting alpha-4 and alpha-5 GABA(a) receptors, which are useful for treating airway hyperresponsiveness and inflammation in asthma. The second patent also focuses on substituted benzo[f]imidazo[1,5-a][1,4]diazepines, emphasizing their selective partitioning to the peripheral compartment and reduced central nervous system effects.

Career Highlights

Throughout her career, Rajwana has worked with notable organizations such as the UWM Research Foundation, Inc. and Columbia University. Her research has contributed to a deeper understanding of GABA(a) receptor modulation and its implications for respiratory health.

Collaborations

Rajwana has collaborated with esteemed colleagues, including Alexander E Arnold and Douglas C Stafford. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Rajwana Jahan is a trailblazer in the field of pharmacology, with her innovative patents addressing critical health issues related to asthma. Her work exemplifies the importance of research and collaboration in advancing medical science.